Immunotherapy For US Patients With Metastatic Cancer at the End of Life

JAMA Oncol. 2024 Aug 1;10(8):1133-1134. doi: 10.1001/jamaoncol.2024.1563.
No abstract available

MeSH terms

  • Humans
  • Immunotherapy* / methods
  • Neoplasm Metastasis*
  • Neoplasms* / therapy
  • Terminal Care
  • United States